Clinical research plays a fundamental role in the development and validation of new healthcare solutions. Within this context, CROs in clinical research support the generation of scientific evidence required to demonstrate the safety and clinical effectiveness of medicines, medical devices and in vitro diagnostics before they become widely available.
Table of Contents
However, this process requires that studies are conducted under controlled and traceable conditions, in alignment with regulatory requirements. Therefore, the ability to execute clinical research in a structured manner directly influences whether development programmes can progress towards regulatory approval.
In this context, CROs in clinical research have become central actors. By managing and conducting studies on behalf of sponsors, they ensure that scientific objectives are translated into credible and compliant evidence.
The regulatory framework of clinical research
The development of new healthcare products takes place within a framework of regulatory and ethical constraints that define how evidence must be generated. These requirements vary depending on the type of product and the country where the study takes place.
However, all clinical trials must follow internationally recognised standards to guarantee that results are both scientifically valid and acceptable for regulatory evaluation.
Good Clinical Practice (GCP) provides the foundation for this framework by establishing how studies are designed, conducted, recorded and reported. Its objective is to protect participants and ensure the credibility of the data generated. Therefore, compliance with GCP principles and regulatory requirements is essential to obtain market approval and validate clinical research outcomes.
In practice, this means that clinical studies must be conducted under controlled and traceable conditions, with consistent procedures across all stages. As a result, the way studies are executed directly influences the reliability of the evidence produced and its acceptance by regulatory authorities.
How CROs in clinical research enable compliant and high-quality studies
CROs in clinical research are companies that act on behalf of sponsors to manage and conduct clinical studies while ensuring compliance with regulatory and ethical standards.
Their involvement spans the entire research lifecycle, supporting the development of healthcare products from early stages through to post-marketing studies.
In addition, CROs operate as third-party partners within clinical studies, facilitating communication and coordination between sponsors and clinical sites. This role becomes particularly relevant in studies conducted across multiple sites or countries, where consistent execution is required to maintain data reliability and compliance.
Sponsors engaging CROs in clinical research include pharmaceutical and biotechnology companies, hospitals, academic institutions and public organisations. In this context, CROs provide support through the planning, management and execution of preclinical, clinical and non-clinical studies, ensuring that activities are conducted in accordance with the study protocol and applicable regulations.
How CROs in clinical research manage operational and scientific responsibilities
The support of CROs extends across a set of core services that collectively enable consistent study execution across sites and stakeholders:
- Study management: ensures coordination and execution of clinical studies, including oversight of laboratories and pharmacy management to guarantee proper handling and traceability of investigational medicinal products;
- Monitoring: verifies that studies are conducted according to the protocol, regulatory requirements and GCP guidelines;
- Pharmacovigilance: focuses on the detection, evaluation and reporting of adverse events, supporting continuous monitoring of participant safety;
- Data management and biostatistics: supports the collection, validation, analysis and interpretation of clinical trial data;
- Medical writing: includes the preparation of essential documentation such as study protocols, informed consent forms and clinical study reports;
- Regulatory affairs: manages submissions to health authorities and ethics committees while ensuring compliance with national and international regulations.
CROs in clinical research are therefore able to manage studies as integrated systems. In addition, they support patient recruitment strategies and guarantee that investigators and site personnel are prepared to conduct the study in accordance with protocol and regulatory requirements, maintaining consistency across all stages of development.
How CROs in clinical research support development across phases and study designs
Clinical development progresses through sequential phases following preclinical research, each with specific objectives and requirements. Therefore, the structure and execution of studies must adapt to the characteristics of each phase while maintaining consistency in regulatory compliance and data quality:
- Phase I involves the first administration of the investigational product in humans, typically with a small number of participants to evaluate safety, tolerability and pharmacokinetic and pharmacodynamic profiles;
- Phase II introduces patients with the target condition to assess preliminary efficacy while continuing safety evaluation;
- Phase III expands the scale of investigation to confirm effectiveness, monitor side effects and compare the intervention with existing treatments or placebo, supporting submission for market approval;
- Phase IV studies are conducted after authorisation to monitor long-term safety and effectiveness.
CROs in clinical research cover both interventional and observational studies across these phases, whether conducted at a single site or across multiple centres and countries.
Within this framework, VectorB2B operates across the clinical research lifecycle, combining operational coordination with regulatory and scientific expertise. This integrated approach enables sponsors to manage complex studies with greater control, maintaining alignment with both protocol requirements and regulatory expectations.
To learn more about how these capabilities can support your development programme, explore our services or get in touch with our team.
Frequently asked questions (FAQ)
1. What distinguishes a CRO from other external service providers in healthcare research?
CROs are responsible for the management and execution of clinical studies on behalf of sponsors. Their role extends beyond individual services, ensuring coordination and regulatory compliance across the study lifecycle.
2. Can CROs support international multicentre studies under different regulatory frameworks?
Yes. CROs are equipped to manage studies across multiple countries, adapting to local regulatory requirements while maintaining consistency in execution, data quality and documentation.
3. What risks arise when clinical studies lack specialised operational support?
Without structured support, studies may face protocol deviations, inconsistent data, regulatory challenges and delays in timelines.
VectorB2B Articles
Insights and analysis across the life sciences ecosystem, from research and development to regulatory, operational and strategic frameworks.
Find something interesting?
Share it with your peers!
Article topics
Explore other articles
